Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

The "AI-based Clinical Trials Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The AI-based clinical trials market is driving a fundamental transformation in ...

Advances in biomarker-driven and individualized approaches in neurology and psychiatry will require new frameworks for value ...

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of ...

Atkins is leveraging a partnership with reality TV star Heather Gay and early clinical trial data to reposition nutrition as ...

Corvus Pharmaceuticals, Inc. jumps 165% on Phase 1 soquelitinib atopic dermatitis data; learn key efficacy, funding, and ...

In today's healthcare environment, securing regulatory approval is only the beginning. The real challenge lies in ensuring ...

CKD patients face higher CVD risk, with dyslipidemia differing from the general population, necessitating tailored lipid ...

National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple ...

Janus Henderson Enterprise Fund outperformed the Russell Midcap Growth Index as healthcare stock selection drove gains.

While sponsors are looking to integrate AI into their trials, fixing the core issues is vital, experts say.

The pill version of Wegovy seems to work just as well as the injectable form, but there are some key differences between the ...